Literature DB >> 8902567

Skin graft reconstruction of the composite resection defect.

A Alvi1, E N Myers.   

Abstract

BACKGROUND: Reconstruction of the composite resection defect should provide for adequate speech and swallowing functions. Poorly designed reconstructive efforts can result in significant oral dysfunction. The composite resection defect can be reconstructed by a variety of methods. The split-thickness skin-graft method provides excellent speech and swallowing functions with minimal morbidity.
METHODS: Forty-three patients who underwent composite resections and were reconstructed by split-thickness skin graft (STSG) were analyzed. The patients' charts were reviewed for oncologic outcome, speech and swallowing functions, and length of hospital stay.
RESULTS: Speech and swallowing functions were excellent. At last follow-up, more than 90% of the patients tolerated either a soft or regular diet. The length of hospital stay was only 13 and 18 days for patients who underwent marginal and lateral segmental mandibulectomy, respectively. There were few complications. Radiation therapy had no adverse effects on the grafts.
CONCLUSION: The STSG method is our preferred method for reconstruction of marginal or lateral segmental mandibulectomy defects that do not require tissue bulk.

Entities:  

Mesh:

Year:  1996        PMID: 8902567     DOI: 10.1002/(SICI)1097-0347(199611/12)18:6<538::AID-HED8>3.0.CO;2-3

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Change in reimbursement and costs in German oncological head and neck surgery over the last decade: ablative tongue cancer surgery and reconstruction with split-thickness skin graft vs. microvascular radial forearm flap.

Authors:  Sebastian Hoefert; Oliver Lotter
Journal:  Clin Oral Investig       Date:  2017-11-09       Impact factor: 3.573

2.  Tongue reconstruction post partial glossectomy during the COVID-19 pandemic. A case report.

Authors:  Albaraa Y Alsini; Suhail Sayed; Hadad Hussein Alkaf; Sherif K Abdelmonim; Mohammed Ali Alessa
Journal:  Ann Med Surg (Lond)       Date:  2020-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.